Lupin Pharmaceuticals

Lupin Pharmaceuticals, Inc. is the U.S. subsidiary of Lupin Limited, a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position in India and the U.S. across multiple therapy areas, including respiratory, cardiovascular, anti-diabetic, anti-infective, gastrointestinal, central nervous system, and women's health.

In the U.S., Lupin has been expanding its footprint with headquarters in Naples, Florida, corporate offices in Bridgewater, New Jersey, and R&D and manufacturing facilities in Coral Springs, Florida, and Somerset, New Jersey. Lupin has 15 state-of-the-art manufacturing sites and 7 research centers globally, along with a dedicated workforce of over 24,000 professionals.